First Manhattan’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.8M Sell
73,682
-32,315
-30% -$32.8M 0.19% 64
2025
Q4
$114M Sell
105,997
-5,240
-5% -$5.01M 0.3% 52
2025
Q3
$84.9M Buy
111,237
+51,983
+88% +$38.7M 0.22% 61
2025
Q2
$46.2M Buy
59,254
+3,437
+6% +$2.67M 0.13% 74
2025
Q1
$46.1M Sell
55,817
-2,382
-4% -$1.98M 0.13% 71
2024
Q4
$45.1M Sell
58,199
-1,267
-2% -$1.05M 0.13% 70
2024
Q3
$52.7M Sell
59,466
-2,502
-4% -$2.25M 0.16% 65
2024
Q2
$56.1M Buy
61,968
+8,506
+16% +$6.8M 0.18% 62
2024
Q1
$41.6M Sell
53,462
-5,129
-9% -$3.65M 0.13% 68
2023
Q4
$34.2M Buy
58,591
+99
+0.2% +$57.8K 0.12% 72
2023
Q3
$31.4M Sell
58,492
-2,293
-4% -$1.18M 0.12% 77
2023
Q2
$28.5M Sell
60,785
-23,535
-28% -$9.87M 0.1% 81
2023
Q1
$29M Sell
84,320
-3,750
-4% -$1.26M 0.11% 81
2022
Q4
$32.2M Sell
88,070
-33,078
-27% -$11.7M 0.12% 76
2022
Q3
$39.2M Sell
121,148
-10,502
-8% -$3.33M 0.17% 60
2022
Q2
$42.7M Sell
131,650
-85
-0.1% -$25.5K 0.17% 62
2022
Q1
$37.7M Buy
131,735
+5,223
+4% +$1.34M 0.12% 77
2021
Q4
$34.9M Buy
126,512
+18,618
+17% +$4.72M 0.12% 80
2021
Q3
$24.9M Sell
107,894
-217
-0.2% -$53.6K 0.09% 98
2021
Q2
$24.8M Sell
108,111
-3,005
-3% -$604K 0.09% 103
2021
Q1
$20.8M Buy
111,116
+6,766
+6% +$1.32M 0.09% 109
2020
Q4
$17.6M Sell
104,350
-1,055
-1% -$158K 0.08% 109
2020
Q3
$15.6M Buy
105,405
+359
+0.3% +$55.6K 0.08% 111
2020
Q2
$17.2M Sell
105,046
-338
-0.3% -$51.9K 0.1% 103
2020
Q1
$14.6M Sell
105,384
-1,261
-1% -$173K 0.09% 112
2019
Q4
$14M Sell
106,645
-5,346
-5% -$620K 0.07% 136
2019
Q3
$12.5M Sell
111,991
-4,124
-4% -$459K 0.07% 147
2019
Q2
$12.9M Sell
116,115
-100
-0.1% -$11.8K 0.07% 145
2019
Q1
$15.1M Sell
116,215
-4,331
-4% -$527K 0.09% 127
2018
Q4
$13.9M Sell
120,546
-1,045
-0.9% -$117K 0.09% 128
2018
Q3
$13M Sell
121,591
-1,170
-1% -$117K 0.07% 161
2018
Q2
$10.5M Sell
122,761
-700
-0.6% -$57.5K 0.06% 177
2018
Q1
$9.55M Sell
123,461
-1,029
-0.8% -$82.8K 0.05% 189
2017
Q4
$10.5M Buy
124,490
+395
+0.3% +$33.6K 0.06% 184
2017
Q3
$10.6M Buy
124,095
+623
+0.5% +$51.1K 0.06% 183
2017
Q2
$10.2M Sell
123,472
-2,450
-2% -$200K 0.06% 176
2017
Q1
$10.6M Sell
125,922
-941
-0.7% -$75.4K 0.06% 166
2016
Q4
$9.33M Buy
126,863
+2,943
+2% +$219K 0.06% 179
2016
Q3
$9.95M Sell
123,920
-578
-0.5% -$46.3K 0.06% 179
2016
Q2
$9.8M Sell
124,498
-5
-0% -$376 0.06% 179
2016
Q1
$8.96M Sell
124,503
-6,165
-5% -$466K 0.06% 176
2015
Q4
$11M Sell
130,668
-4,050
-3% -$336K 0.07% 163
2015
Q3
$11.3M Sell
134,718
-843
-0.6% -$71.2K 0.07% 151
2015
Q2
$11.3M Sell
135,561
-5,600
-4% -$427K 0.07% 164
2015
Q1
$10.3M Sell
141,161
-1,349
-0.9% -$96K 0.06% 175
2014
Q4
$9.83M Sell
142,510
-241
-0.2% -$16.3K 0.06% 178
2014
Q3
$9.26M Sell
142,751
-400
-0.3% -$25.3K 0.05% 180
2014
Q2
$8.9M Sell
143,151
-1,737
-1% -$104K 0.06% 184
2014
Q1
$8.53M Sell
144,888
-3,250
-2% -$181K 0.06% 183
2013
Q4
$7.55M Buy
148,138
+37,670
+34% +$1.89M 0.05% 198
2013
Q3
$5.56M Sell
110,468
-137
-0.1% -$7.17K 0.04% 220
2013
Q2
$5.92M Buy
+110,605
New +$6.02M 0.04% 214

Other funds holding LLY

First Manhattan's LLY Position: Q1 2026 in Review

First Manhattan reduced its Eli Lilly (LLY) stake by 30% in Q1 2026, selling an estimated $32.8M and leaving 73,682 shares worth $67.8M. The position accounts for 0.19% of the portfolio, ranked #64.

First Manhattan first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $114M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • First Manhattan held 73,682 shares of Eli Lilly worth $67.8M as of Q1 2026.
  • First Manhattan sold 32,315 Eli Lilly shares in Q1 2026, an estimated $32.8M.
  • Eli Lilly made up 0.19% of First Manhattan's portfolio in Q1 2026, its #64 holding.
  • First Manhattan first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's Eli Lilly position peaked at $114M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.